1. Boghossian TA, Rashid FJ, Thompson W, Welch V, Moayyedi P, Rojas-Fernandez C, Pottie K, Farrell B. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews 2017, Issue 3. Art. No.: CD011969. DOI: 10.1002/14651858.CD011969.pub2.
  2. Kahrilas PJ, Hirano I. Diseases of the Esophagus. In: Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J. eds. Harrison's Principles of Internal Medicine, 19e New York, NY: McGraw-Hill; 2014. Accessed September 18, 2017.
  3. Katz P, Gerson L, Vela M. Guidelines for the diagnosis and management of gastroesophageal reflux disease. The American Journal Of Gastroenterology [serial online]. March 2013;108(3):308-328. Available from: MEDLINE Complete, Ipswich, MA. Accessed September 18, 2017.
  4. Naunton, M, Peterson, GM, Deeks, LS, Young, H, Kosari, S. We have had a gutful: The need for deprescribing proton pump inhibitors. J Clin Pharm Ther. 2017;1–8. DOI: 10.1111/jcpt.12613
  5. Wolfe, M. Overview and comparison of the proton pump inhibitors for treatment of acid-related disorders. Up To Date 2017.